Reckitt Benckiser Group - RKT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 7,516.67
  • Forecasted Upside: 30.63%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
GBX 5,754
▼ -30 (-0.52%)

This chart shows the closing price for RKT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Reckitt Benckiser Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RKT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RKT

Analyst Price Target is GBX 7,516.67
▲ +30.63% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Reckitt Benckiser Group in the last 3 months. The average price target is GBX 7,516.67, with a high forecast of GBX 8,500 and a low forecast of GBX 6,750. The average price target represents a 30.63% upside from the last price of GBX 5,754.

This chart shows the closing price for RKT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 polled investment analysts is to buy stock in Reckitt Benckiser Group.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/11/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/9/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/8/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/7/2023

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/18/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 6,750
10/27/2022BarclaysLower TargetOverweightGBX 8,900 ➝ GBX 8,200
10/27/2022Deutsche Bank AktiengesellschaftLower TargetBuyGBX 6,900 ➝ GBX 6,750
10/27/2022Berenberg BankLower TargetBuyGBX 8,200 ➝ GBX 7,050
10/7/2022Royal Bank of CanadaBoost TargetOutperformGBX 7,200 ➝ GBX 7,600
10/6/2022Deutsche Bank AktiengesellschaftLower TargetBuyGBX 7,200 ➝ GBX 6,900
10/3/2022BarclaysLower TargetOverweightGBX 9,500 ➝ GBX 8,900
9/2/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
7/28/2022Berenberg BankBoost TargetBuyGBX 7,375 ➝ GBX 8,050
7/28/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
7/19/2022Berenberg BankLower TargetBuyGBX 7,700 ➝ GBX 7,375
7/6/2022JPMorgan Chase & Co.Reiterated RatingOverweight
6/29/2022Royal Bank of CanadaReiterated RatingOutperformGBX 7,000
6/24/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
6/22/2022JPMorgan Chase & Co.Reiterated RatingOverweight
6/1/2022Royal Bank of CanadaReiterated RatingOutperformGBX 7,000
5/26/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
5/20/2022BarclaysReiterated RatingOverweightGBX 9,300
5/18/2022Royal Bank of CanadaUpgradeOutperformGBX 5,900 ➝ GBX 7,000
5/12/2022JPMorgan Chase & Co.Reiterated RatingOverweight
5/11/2022Morgan StanleyReiterated RatingOverweight
5/9/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
5/3/2022BarclaysBoost TargetOverweightGBX 9,100 ➝ GBX 9,300
4/29/2022Berenberg BankBoost TargetBuyGBX 7,460 ➝ GBX 7,700
4/29/2022Royal Bank of CanadaBoost TargetSector PerformGBX 5,500 ➝ GBX 5,900
4/24/2022Morgan StanleyReiterated RatingOverweightGBX 7,000
4/14/2022Morgan StanleyReiterated RatingOverweightGBX 7,000
4/5/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
4/4/2022JPMorgan Chase & Co.Reiterated RatingOverweight
4/1/2022Royal Bank of CanadaReiterated RatingSector PerformGBX 5,500
4/1/2022BarclaysBoost TargetOverweightGBX 8,800 ➝ GBX 9,100
3/25/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
3/23/2022Berenberg BankLower TargetBuyGBX 7,480 ➝ GBX 7,460
3/4/2022BarclaysReiterated RatingOverweightGBX 8,800
2/25/2022JPMorgan Chase & Co.Reiterated RatingOverweightGBX 8,500
2/18/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
2/18/2022BarclaysLower TargetOverweightGBX 9,400 ➝ GBX 8,800
2/11/2022Berenberg BankReiterated RatingBuyGBX 7,525
2/9/2022Morgan StanleyReiterated RatingOverweight
2/7/2022BarclaysReiterated RatingOverweightGBX 9,400
2/4/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
1/25/2022Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
1/25/2022BarclaysReiterated RatingOverweightGBX 9,400
1/19/2022Berenberg BankBoost TargetBuyGBX 7,170 ➝ GBX 7,525
12/21/2021BarclaysBoost TargetOverweightGBX 8,900 ➝ GBX 9,400
12/16/2021JPMorgan Chase & Co.Reiterated RatingOverweightGBX 8,500
12/14/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
11/9/2021Royal Bank of CanadaReiterated RatingSector PerformGBX 6,200
10/27/2021BarclaysLower TargetOverweightGBX 9,500 ➝ GBX 8,900
10/26/2021Berenberg BankLower TargetBuyGBX 7,870 ➝ GBX 7,170
10/26/2021Royal Bank of CanadaBoost TargetSector PerformGBX 6,000 ➝ GBX 6,200
10/14/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 7,200
10/11/2021Berenberg BankReiterated RatingBuyGBX 7,870
7/28/2021Deutsche Bank AktiengesellschaftLower TargetBuyGBX 8,000 ➝ GBX 7,200
7/28/2021Credit AgricoleLower TargetOutperformGBX 7,800 ➝ GBX 7,100
7/28/2021JPMorgan Chase & Co.Lower TargetOverweightGBX 9,000 ➝ GBX 8,500
7/27/2021Royal Bank of CanadaLower TargetSector PerformGBX 6,500 ➝ GBX 6,000
7/27/2021Berenberg BankLower TargetBuyGBX 8,500 ➝ GBX 7,870
7/1/2021Deutsche Bank AktiengesellschaftLower TargetBuyGBX 8,200 ➝ GBX 8,000
6/7/2021Credit Suisse GroupReiterated RatingOutperformGBX 7,800
5/17/2021Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 8,200
4/28/2021Berenberg BankBoost TargetBuyGBX 8,385 ➝ GBX 8,500
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.14 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
7/12/2022
  • 4 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/11/2022
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
9/10/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/9/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/9/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/8/2023
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/7/2023

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Reckitt Benckiser Group logo
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
Read More

Today's Range

Now: GBX 5,754
Low: 5,718
High: 5,792

50 Day Range

MA: GBX 5,816.31
Low: 5,570
High: 6,038

52 Week Range

Now: GBX 5,754
Low: 5,400
High: 6,824

Volume

903,561 shs

Average Volume

1,361,053 shs

Market Capitalization

£41.18 billion

P/E Ratio

1,353.88

Dividend Yield

3.09%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Reckitt Benckiser Group?

The following equities research analysts have issued reports on Reckitt Benckiser Group in the last twelve months: Barclays PLC, Berenberg Bank, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, and Royal Bank of Canada.
View the latest analyst ratings for RKT.

What is the current price target for Reckitt Benckiser Group?

6 Wall Street analysts have set twelve-month price targets for Reckitt Benckiser Group in the last year. Their average twelve-month price target is GBX 7,516.67, suggesting a possible upside of 30.3%. JPMorgan Chase & Co. has the highest price target set, predicting RKT will reach GBX 8,500 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of GBX 6,750 for Reckitt Benckiser Group in the next year.
View the latest price targets for RKT.

What is the current consensus analyst rating for Reckitt Benckiser Group?

Reckitt Benckiser Group currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RKT will outperform the market and that investors should add to their positions of Reckitt Benckiser Group.
View the latest ratings for RKT.

What other companies compete with Reckitt Benckiser Group?

Other companies that are similar to Reckitt Benckiser Group include Unilever, Imperial Brands, Tesco, British American Tobacco and Diageo. Learn More about companies similar to Reckitt Benckiser Group.

How do I contact Reckitt Benckiser Group's investor relations team?

The company's listed phone number is 44 17 5321 7800. The official website for Reckitt Benckiser Group is www.reckitt.com. Learn More about contacing Reckitt Benckiser Group investor relations.